<unk>  (also marketed as Megimide) is a central nervous system stimulant and antidote for barbiturate poisoning as its chemoreceptor agonism increases mean tidal volume, thereby increasing respiration and the concentration of O2 in blood although it may be theoretically used as a supportive measure in treating any depressant overdose. The drug's synthesis was invented in 1911.
Bemegride
Tiapride
Alizapride
Remoxipride
Thiomersal
Pegvisomant
Lomitapide
Nizatidine